4
Changes in Ownership
Vir Biotechnology, Inc. Filed Acc 0001209191-20-052656
EVP, Research & CSO sold 3,510 shares at $38.00 ($133,380)
- EVP, Research & CSO acquired 3,510 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
Virgin Herbert · EVP, Research & CSO
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2020-09-29 | Exercise or conversion : show line 1 in the form | +3,510 | $1.53 | $5,370 | 27,210 | D |
| 2020-09-29 | Sale : show line 2 in the form | −3,510 | $38.00 | $133,380 | 23,700 | D |
| Open-market sales · 3,510 sh · avg $38.00 · $133,380 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2020-09-29 | Exercise or conversion : show line 3 in the form Stock Option (Right to Buy) | −3,510 | 459,875 | D |
Loading xslF345X03/doc4.xml…